Bromocriptine Improves Central Aortic Stiffness in Adolescents With Type 1 Diabetes: Arterial Health Results From the BCQR-T1D Study

Author:

Schäfer Michal1ORCID,Browne Lorna P.2,Truong Uyen3ORCID,Bjornstad Petter4,Tell Shoshana4,Snell-Bergeon Janet5ORCID,Baumgartner Amy4,Hunter Kendall S.6,Reusch Jane E.B.789,Barker Alex J.26,Nadeau Kristen J.4,Schauer Irene E.789

Affiliation:

1. Division of Pediatric Cardiology, Department of Pediatrics (M.S.), University of Colorado – School of Medicine, Aurora.

2. Department of Radiology (L.P.B., A.J.B.), University of Colorado – School of Medicine, Aurora.

3. Department of Cardiology, Children’s Hospital of Richmond at Virginia Commonwealth University (U.T.).

4. Section of Pediatric Endocrinology, Department of Pediatrics (P.B., S.T., A.B., K.J.N.), University of Colorado – School of Medicine, Aurora.

5. Barbara Davis Center, Department of Medicine (J.S.-B.), University of Colorado – School of Medicine, Aurora.

6. Department of Bioengineering, University of Colorado Denver (K.S.H., A.J.B.).

7. Division of Endocrinology, Department of Medicine (J.E.B.R., I.E.S.), University of Colorado – School of Medicine, Aurora.

8. Center for Women’s Health Research (J.E.B.R., I.E.S.), University of Colorado – School of Medicine, Aurora.

9. Section of Endocrinology, Rocky Mountain Regional VAMC, Aurora, CO (J.E.B.R., I.E.S.).

Abstract

Background: The presence of vascular dysfunction is a well-recognized feature in youth with type 1 diabetes (T1D), accentuating their lifetime risk of cardiovascular events. Therapeutic strategies to mitigate vascular dysfunction are a high clinical priority. In the bromocriptine quick release T1D study (BCQR-T1D), we tested the hypothesis that BCQR would improve vascular health in youth with T1D. Methods: BCQR-T1D was a placebo-controlled, random-order, double-blinded, cross-over study investigating the cardiovascular and metabolic impact of BCQR in T1D. Adolescents in the BCQR-T1D study were randomized 1:1 to phase-1: 4 weeks of BCQR or placebo after which blood pressure and central aortic stiffness measurements by pulse wave velocity, relative area change, and distensibility from phase-contrast magnetic resonance imaging were performed. Following a 4-week washout period, phase 2 was performed in identical fashion with the alternate treatment. Results: Thirty-four adolescents (mean age 15.9±2.6 years, hemoglobin A1c 8.6±1.1%, body mass index percentile 71.4±26.1, median T1D duration 5.8 years) with T1D were enrolled and had magnetic resonance imaging data available. Compared with placebo, BCQR therapy decreased systolic (∆=−5 mmHg [95% CI, −3 to −7]; P <0.001) and diastolic blood pressure (∆=−2 mmHg [95% CI, −4 to 0]; P =0.039). BCQR reduced ascending aortic pulse wave velocity (∆=−0.4 m/s; P =0.018) and increased relative area change (∆=−2.6%, P =0.083) and distensibility (∆=0.08%/mmHg; P =0.017). In the thoraco-abdominal aorta, BCQR decreased pulse wave velocity (∆=−0.2 m/s; P =0.007) and increased distensibility (∆=0.05 %/mmHg; P =0.013). Conclusions: BCQR improved blood pressure and central and peripheral aortic stiffness and pressure hemodynamics in adolescents with T1D over 4 weeks versus placebo. BCQR may improve aortic stiffness in youth with T1D, supporting future longer-term studies.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3